铜梁区优田美甲加盟电话多少钱(泉州市优美美甲加盟电话多少钱) (今日更新中)

LOS ANGELES, April 2 (Xinhua) -- The United States could soon be faced with an epidemic of Non-Alcoholic Fatty Liver Disease ( NAFLD), one of the major contributing factors of chronic liver disease (CLD), the American Association for the Advancement of Science (AAAS) reported Saturday.If the current rates of obesity and diabetes continue for another two decades, the prevalence of NAFLD in the U.S. is expected to increase by 50 percent in 2030, AAAS said.The prediction is based on pre-existing clinical survey data over a 10 year period (1988-1994, 1999-2004 and 2005-2008), which included 39,500 adults from three survey cycles, according to the AAAS.Over the three cycles, the prevalence of NAFLD doubled from 5. 51 percent to 11 percent respectively. Furthermore, during the first survey cycle (1988-1994) 46.8 percent of all CLD's was related to NAFLD but by 2005-2008 this had increased to 75.1 percent. In addition, the prevalence of obesity and diabetes, the two key risk factors for NAFLD also steadily increased."If the obesity epidemic is anything to go by, the U.S. NAFLD epidemic may have a ripple effect worldwide," said Mark Thursz, Vice Secretary of the European Association for the Study of the Liver. "It is imperative that health systems continue to drive effective educational programs to reinforce awareness among the general public to alert them of the risks of obesity and promote the importance of diet and exercise."Non-alcoholic fatty liver disease is fast becoming one of the top concerns for clinicians due to the obesity epidemic and it's potential to progress to advanced liver disease which significantly impacts on overall liver-related mortality, Thursz said in remarks published by AAAS' website EurekAlert.org.NAFLD, considered as one of the major causes of morbidity and mortality worldwide, is the term used to describe fat build-up in liver cells in people who do not drink alcohol excessively. The disease is the most common persistent liver disorder in Western countries with an estimated overall prevalence of 20-30 percent, according to AAAS.NAFLD encompasses a spectrum of liver disease associated with insulin resistance, diabetes and obesity and as such people most at risk of NAFLD are those who are obese, have insulin resistance associated with diabetes, high blood pressure and cholesterol.

COPENHAGEN, April 30 (Xinhua) -- As traditional Chinese medicine (known as TCM in Europe) becomes increasingly popular worldwide and has gradually been regarded as a useful component to Western medical treatments, Denmark is no stranger to such trends.According to a study published by the University of Copenhagen in mid-Feb., up to one-third of Danish hospitals choose complementary or alternative therapies, including TCM methods, to treat pain, cancer, mental disease, tumors and infertility. Acupuncture remains the most widely-practiced form of these treatments, used in some 97 percent of the cases.The nationwide acceptance of acupuncture and massage therapists, the growing ranks of herbal practitioners, and the hosting of an annual pan-Scandinavian TCM conference since 2007, all underline the popularity of alternative medicine, including the TCM, in the country.However, the overall market presence of TCM, and herbal medicines in particular, is relatively small in Denmark and Europe at large. As many European policymakers insist that traditional herbal medicines "are neither scientifically documented nor tested according to Western requirements," these treatments face difficulties in obtaining licenses and boosting sales in Europe.In fact, despite their historical pedigree and widely-accepted efficacy, TCM products are often classified as "healthcare products" or "food," rather than "drugs" in European markets.A big challenge for TCM products to gain more access to the continent is the EU's Traditional Herbal Medicinal Products Directive, which stipulates that all such products must obtain authorization if they are to be sold within the EU, starting May 1, 2011.The directive says producers must prove the product in question has been used for 30 years, 15 of which within the EU, so as to ensure its safety.While licensing is expected to be onerous and expensive, Denmark has tried to bring TCM products into the Western medical mainstream from as early as 2005. The country's well-developed biochemical and medical industry, modernized agriculture and horticulture sectors and a strong track record of cooperative research in these fields, has helped TCM's cause.For instance, Traditional Complementary Medicine Denmark, a company helping herbal product makers market their goods in Western countries, uses modern biotechnology processes and clinical trials to scientifically verify and document the efficacy of existing herbal medicines.It also advises herbal product makers on how to align their standards with European requirements so as to acquire the necessary sales licenses. Sometimes, simple solutions like clearer and more detailed labeling of a TCM product's ingredients can help improve its marketability. Patent applications and drug approvals procedures must follow, before the product can access the EU pharmaceutical market, usually in pill form.Investing in herbal medicine also makes financial sense for Denmark, as it is encourages development of low-bulk, high-value agricultural products, which can be easily transported all over the globe.Development Centre Aarslev, a Danish agro-research body and partner of TCM Denmark, studies the active ingredients contained in medicinal plants and their impact on human health conditions such as cardiovascular problems, diabetes and allergies. One of the earliest collaborations it undertook with a producer of herbal medicine showed the effectiveness of extracts from the hips of the dog rose plant in treating rheumatoid arthritis.A spokesperson for the institution said, "We have documented analytical evidence which shows that arthritis patients can reduce their consumption of conventional anti-arthritis drugs by up to 50 percent, if they combine them with the herbal drug based on dog rose hips."Given Denmark's population of 5.5 million people, this could translate into savings of 200 million U.S. dollars a year on anti-arthritis medication, the spokesperson added.Other plant-based interventions could hold wider public health benefits. TCM practitioners say herbal medicines can improve blood circulation in humans, and contain naturally-occurring antioxidants which can reduce the risks of heart attacks and better regulate cardiovascular functions. This has potentially wide-ranging benefit for Western societies, where heart disease is a major threat.Heart disease was the most common cause of death in Denmark until 2000, and cardiovascular disease the commonest until 2008, with cancer now ranking the biggest killer.In fact, TCM herbal remedies are also considered a good choice for cancer treatment, as certain plants contain hormone-like substance which can influence hormone-dependent cancers, such as breast and prostate cancer.TCM supporters say the obvious benefit of such an intervention is the avoidance of more commonly-used chemotherapy and radiation treatments which often produce severe side-effects in patients. Relevant herbal therapies can help strengthen cancer patient's immune system, reduce side-effects of chemotherapy and radiation therapy, and alleviate other symptoms of the disease.Given the many potential benefits of TCM, the EU's tightening of rules may appear harsh. Still, TCM is considered a relatively novel approach to medicine in Europe. Moreover, the dominant market share and general clout of the chemical-based, Western pharmaceutical industry also makes it difficult for traditional remedies to stake their claim.

WASHINGTON, April 3 (Xinhua) -- In the largest study of its kind, researchers from a consortium led by the University of Pennsylvania School of Medicine, the University of Miami, and the Boston University School of Medicine, identified four new genes linked to Alzheimer's disease. The findings appeared Sunday in the current issue of Nature Genetics.Each gene individually adds to the risk of having this common form of dementia later in life. These new genes offer a portal into what causes Alzheimer's disease and is a major advance in the field.The study, conducted by the Alzheimer's Disease Genetics Consortium, reports genetic analysis of more than 11,000 people with Alzheimer's disease and a nearly equal number of elderly people who have no symptoms of dementia. Three other consortia contributed confirming data from additional people, bringing the total number of people analyzed to over 54,000. The consortium also contributed to the identification of a fifth gene reported by other groups of investigators from the United States, the United Kingdom, France, and other European countries.The study is the result of a large collaborative effort with investigators from 44 universities and research institutions in the United States, led by Gerard Schellenberg at University of Pennsylvania."This is the culmination of years of work on Alzheimer's disease by a large number of scientists, yet it is just the beginning in defining how genes influence memory and intellectual function as we age. We are all tremendously excited by our progress so far, but much remains to be done, both in understanding the genetics and in defining how these genes influence the disease process," Schellenberg said.Until recently, only four genes associated with late-onset Alzheimer's have been confirmed, with the gene for apolipoprotein E-e4, APOE-e4, having the largest effect on risk. The Nature Genetics studies add another four -- MS4A, CD2AP, CD33, and EPHA1 -- and contribute to identifying and confirming two other genes, BIN1 and ABCA7, thereby doubling the number of genes known to contribute Alzheimer's disease.

BAODING, Hebei, Feb. 3 (Xinhua) -- Chinese President Hu Jintao Thursday called for efforts to promote welfare for senior citizens and vowed to improve the country's health care system to make medical services more affordable.Hu made the call during a three-day inspection tour in Baoding City of northern province of Hebei starting on Tuesday, during which he visited orphans, talked to senior citizens and extended festival greetings to local residents.At a nursing center in Shunping County of Baoding City, Hu offered New Year greetings to senior citizens, orphans and staff of the center.Hu wished the senior citizens good health and a long life, encouraged orphans to study hard, and thanked the staff for the care given to the aged.The Communist Party of China (CPC) and the government will make strenuous efforts to improve the welfare of seniors and make sure their difficulties are solved and they have access to better services, Hu said.When visiting Zhao Helou, a Baoding retiree who has been hospitalized several times and living in difficult circumstances, Hu promised assistance from the Party and the government to help Zhao tide over her problems.The health care and medical insurance system would be improved in the future to tackle people's difficulties in medical care, Hu promised.During his visit to Baoding, Hu also inspected drought conditions at wheat fields, joined villagers during New Year celebrations and extended Spring Festival greetings to passengers, station workers and volunteers.Hu, who is also general secretary of the CPC Central Committee, was briefed on the work of Hebei's provincial committee of the CPC and the provincial government during his tour.

BEIJING, May 12 (Xinhuanet) -- Italian archaeologists are digging the remains of Lisa Gherardini, a 16th-century woman who is widely believed to be the model for the famous portrait Mona Lisa, AFP reported on Wednesday.The team of historians say they will try to find the remains using geo-radar equipment and then try to re-create a likeness of what the woman, Lisa Gherardini, would have looked like to compare her to Leonardo Da Vinci's Mona Lisa.Gherardini (1479-1542), also known by her married name as Lisa del Giocondo, was the wife of a Florentine silk merchant and is widely believed to have been the model for the  portrait that now hangs in the Louvre in Paris.But the issue has never been settled definitively and mystery still shrouds the model's enigmatic expression and other details of the portrait.

来源：资阳报